E. Michael Gertz

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index7.2kcitations152works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(45), CAR-T cell therapy research(27), Cutaneous Melanoma Detection and Management(24), Cancer Immunotherapy and Biomarkers(23), Melanoma and MAPK Pathways(22)

Publications152 total

Hvordan unge kvinder oplever, at køn spiller ind i læring af naturvidenskab og matematik på STX
MONA - Matematik- og Naturfagsdidaktik·2025Open Access
A machine learning framework for supervised treatment response prediction from tumor transcriptomics: A large-scale pan-cancer study
2025Open Access
Retraction Note: Predicting cancer prognosis and drug response from the tumor microbiome
Nature Communications·2025Open Access
Supplementary Material from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Table S1 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Table S3 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Data from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Table S5 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Table S6 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Table S4 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Table S2 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
2024Open Access
Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
Cancer Research·2024· 15 citedOpen Access
Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes
Science Advances·2024· 16 citedOpen Access
Apheresis Product Characteristics Predict Response to CD22 CAR T-Cell Therapy in Pediatric and Young Adult Patients with B-ALL
Transplantation and Cellular Therapy·2024
Impact of fludarabine exposure on the depth and duration of lymphopenia and CAR T-cell outcomes.
Journal of Clinical Oncology·2023
Medication effects on the gut microbiome in allo-HCT
Cell·2023· 2 cited
Supplementary Data from Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti–PD-1 Therapy
2023Open Access
Supplementary Table from Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti–PD-1 Therapy
2023Open Access
Supplementary Table from Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti–PD-1 Therapy
2023Open Access
Supplementary Table from Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti–PD-1 Therapy
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Alejandro A. Schäffer(37), Thomas Ried(10), Kerstin Heselmeyer‐Haddad(9), Richa Agarwala(8), Russell Schwartz(8), Dietmar Pfeifer(7), Eytan Ruppin(7), Bodo Grimbacher(6), Christoph Klein(6), Irianna Torres(6), Stephen F. Altschul(5), Yi‐Kuo Yu(5), Darawalee Wangsa(5), Daniel Kotlarz(4), Jana Diestelhorst(4), Hans Kreipe(4), Yue Hu(4), Jens K. Habermann(4), Daniela Hirsch(4), Ulrich Baumann(3)